Q1. How many patients have been treated (for any disease) in the last three months with:
a. Benralizumab
b. Omalizumab
c. Reslizumab
d. Mepolizumab
Q2. How many patients have been treated in the last three months, for asthma ONLY, with:
a. Dupilumab
b. Upadacitinib
Q3. How many patients have been treated (with any medication) for severe asthma in the last three months? Of these patients, how many were children?
